PL1890546T3 - Sposób poprawiania biodostępności kurkuminy - Google Patents

Sposób poprawiania biodostępności kurkuminy

Info

Publication number
PL1890546T3
PL1890546T3 PL05750098T PL05750098T PL1890546T3 PL 1890546 T3 PL1890546 T3 PL 1890546T3 PL 05750098 T PL05750098 T PL 05750098T PL 05750098 T PL05750098 T PL 05750098T PL 1890546 T3 PL1890546 T3 PL 1890546T3
Authority
PL
Poland
Prior art keywords
curcumin
bioavailability
improving
Prior art date
Application number
PL05750098T
Other languages
English (en)
Inventor
Benny Antony
Original Assignee
Benny Antony
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37481273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1890546(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Benny Antony filed Critical Benny Antony
Publication of PL1890546T3 publication Critical patent/PL1890546T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/40—Liliopsida [monocotyledons]
    • A01N65/48—Zingiberaceae [Ginger family], e.g. ginger or galangal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dentistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Agronomy & Crop Science (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
PL05750098T 2005-05-30 2005-05-30 Sposób poprawiania biodostępności kurkuminy PL1890546T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IN2005/000176 WO2006129323A1 (en) 2005-05-30 2005-05-30 A composition to enhance the bioavailability of curcumin
EP05750098.5A EP1890546B1 (en) 2005-05-30 2005-05-30 Method for improving the bioavailability of curcumin

Publications (1)

Publication Number Publication Date
PL1890546T3 true PL1890546T3 (pl) 2019-04-30

Family

ID=37481273

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05750098T PL1890546T3 (pl) 2005-05-30 2005-05-30 Sposób poprawiania biodostępności kurkuminy

Country Status (9)

Country Link
US (7) US7736679B2 (pl)
EP (1) EP1890546B1 (pl)
JP (1) JP5039032B2 (pl)
DK (1) DK1890546T3 (pl)
ES (1) ES2709653T3 (pl)
HU (1) HUE042590T2 (pl)
PL (1) PL1890546T3 (pl)
PT (1) PT1890546T (pl)
WO (1) WO2006129323A1 (pl)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170042833A1 (en) * 2014-03-12 2017-02-16 Benny Antony Formulation of Curcuminoids with Enhanced Bioavailability of Curcumin, Demethoxycurcumin, Bisdemethoxycurcumin and method of preparation and uses thereof
US10286027B2 (en) * 2005-05-30 2019-05-14 Arjuna Natural Extracts, Ltd. Sustained release formulations of curcuminoids and method of preparation thereof
WO2011125070A2 (en) * 2010-04-05 2011-10-13 Benny Antony Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof
US8859020B2 (en) * 2005-05-30 2014-10-14 Benny Antony Treatment of alzheimer's with a curcuminoid mixture and essential oil of turmeric having 45% Ar-turmerone
WO2014068597A2 (en) * 2012-11-03 2014-05-08 Benny Antony Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof
US12053438B2 (en) * 2005-05-30 2024-08-06 Arjuna Natural Private Limited Formulation of curcuminoids with enhanced bioavailability of curcumin, demethoxycurcumin, bisdemethoxycurcumin and method of preparation and uses thereof
US9492402B2 (en) * 2005-05-30 2016-11-15 Benny Antony Formulation of curcuminoids with enhanced bioavailability of curcumin, demethoxycurcumin, bisdemethoxycurcumin and method of preparation and uses thereof
PT1890546T (pt) * 2005-05-30 2019-01-23 Antony Benny Método para melhorar a biodisponibilidade da curcumina
EP2315063A4 (en) * 2008-08-19 2011-08-17 Rohm Co Ltd Camera
US20120003177A1 (en) * 2008-09-17 2012-01-05 Youqing Shen Curcumin-containing polymers and water-soluble curcumin derivatives as prodrugs of prodrug carriers
US20100255133A1 (en) * 2009-04-07 2010-10-07 Shodoshima Healthy Land Co., Ltd. Extracted olive oil and production method thereof
WO2011082290A2 (en) 2009-12-31 2011-07-07 Organomed Corporation Formulations from natural products, turmeric, and aspirin
US9393198B2 (en) * 2010-03-22 2016-07-19 Signpath Pharma Inc. Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders
WO2012023146A1 (en) * 2010-08-16 2012-02-23 Benny Antony A pharmaceutical composition of reformulated turmeric extract and a method thereof
US8785380B2 (en) 2011-02-01 2014-07-22 M/S Akay Flavours & Aromatics Pvt Ltd. Formulation containing curcuminoids exhibiting enhanced bioavailability
EP2709607B1 (en) 2011-05-16 2017-01-11 OmniActive Health Technologies Limited A water soluble composition comprising curcumin having enhanced bioavailability and process thereof
US10117881B2 (en) 2011-06-03 2018-11-06 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies
US10349884B2 (en) 2011-06-03 2019-07-16 Sighpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
US10449193B2 (en) 2011-06-03 2019-10-22 Signpath Pharma Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies
US12004868B2 (en) 2011-06-03 2024-06-11 Signpath Pharma Inc. Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel
US10238602B2 (en) 2011-06-03 2019-03-26 Signpath Pharma, Inc. Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies
CA2836904C (en) 2011-06-03 2019-09-24 Signpath Pharma Inc. Liposomal mitigation of drug-induced long qt syndrome and potassium delayed-rectifier current
ITPD20120021A1 (it) 2012-01-26 2013-07-27 Fidia Farmaceutici "nuove composizioni farmaceutiche contenenti fosfatidilserina e curcumina".
JP5511895B2 (ja) * 2012-06-07 2014-06-04 アントニイ ベニー クルクミンの生物学的利用率を向上させるための組成物
AU2013274105A1 (en) 2012-06-14 2014-12-18 Signpath Pharma, Inc. Method and system for measuring the pharmacokinetics of liposomal curcumin and its metabolite tetrahydrocurcumin
US20140056828A1 (en) 2012-08-21 2014-02-27 Indiran Pather Novel formulations and uses for curcuma extracts
CA2882978A1 (en) 2012-08-31 2014-03-06 University Of North Texas Health Science Center Curcumin-er, a liposomal-plga sustained release nanocurcumin for minimizing qt prolongation for cancer therapy
CN103450115A (zh) * 2013-04-19 2013-12-18 南京中医药大学 姜黄素衍生物及其作为大麻素受体调节剂的应用
US11338005B2 (en) 2013-06-28 2022-05-24 Arjuna Natural Private Limited Medicinal composition of amaranth origin for cardiovascular treatment
WO2015025263A1 (en) * 2013-08-19 2015-02-26 Plant Lipids Private Limited A novel composition of curcumin with enhanced bioavailability
CA2933204C (en) 2013-12-18 2020-04-28 Signpath Pharma, Inc. Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel
CN103948874A (zh) * 2014-05-13 2014-07-30 陈文才 治疗肿瘤的中药及其应用方法
US10085951B2 (en) 2014-12-11 2018-10-02 Designs For Health, Inc. Curcuminoid formulations and related methods of treatment
CN104840904A (zh) * 2015-06-12 2015-08-19 李兰珍 一种治疗乳腺增生的中药组合物
ES2881337T3 (es) * 2016-03-25 2021-11-29 Biopteq Sprl Purificación de la curcumina
KR102603673B1 (ko) 2016-04-27 2023-11-17 사인패스 파마 인코포레이티드 약물 유발된 방실 차단의 방지
US10076552B2 (en) 2016-08-09 2018-09-18 DATT MEDIPRODUCTS LIMITED and DATT LIFE SCIENCE PVT. LTD. Multifunctional formulation comprised of natural ingredients and method of preparation/manufacturing thereof
WO2018185780A1 (en) * 2017-04-04 2018-10-11 Olene Life Sciences Private Limited Bioavailable composition for turmeric oleoresin
JP7671693B2 (ja) * 2018-10-23 2025-05-02 スタビコン ライフ サイエンシズ プライベート リミテッド 非クルクミノイドの水溶性粒子とクルクミノイドの水溶性粒子から構成される製剤
WO2020089944A1 (en) * 2018-11-03 2020-05-07 Olene Life Sciences Private Limited Process for preparing an herbal extract and compositions thereof
JP2022536340A (ja) * 2019-06-11 2022-08-15 オレーヌ ライフ サイエンシズ プライベート リミテッド 生物学的に利用可能なウコン組成物およびそれを調製するための方法
BR112022016081A2 (pt) 2020-02-24 2022-10-04 Quincy Bioscience Llc Composições contendo apoaequorina e curcumina e métodos
GB202011069D0 (en) 2020-07-17 2020-09-02 Univ Of Lincoln New curcumin products and uses
EP4316471A4 (en) 2021-04-01 2025-03-19 SNJ Pharma Inc Oral nanoparticles for bioactive compound, and method of preparing same
US12251415B1 (en) 2024-01-18 2025-03-18 Arjuna Natural Private Limited Curcuminoid composition of curcumin-keto, method of preparation and use thereof
WO2025153853A1 (en) * 2024-01-18 2025-07-24 Arjuna Natural Private Limited Curcuminoid composition of curcumin-keto, method of preparation and use thereof

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340250A (en) 1963-09-18 1967-09-05 Griffith Laboratories Extracting values from turmeric
US5120538A (en) 1990-02-05 1992-06-09 Pt Darya-Varia Laboratoria Combinations of compounds isolated from curcuma spp as anti-inflammatory agents
US6245350B1 (en) * 1994-12-16 2001-06-12 Warner-Lambert Company Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
US5536506A (en) * 1995-02-24 1996-07-16 Sabinsa Corporation Use of piperine to increase the bioavailability of nutritional compounds
US5861415A (en) * 1996-07-12 1999-01-19 Sami Chemicals & Extracts, Ltd. Bioprotectant composition, method of use and extraction process of curcuminoids
US6235287B1 (en) * 1998-01-09 2001-05-22 Ida Development A/S Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments
US6224871B1 (en) * 1998-03-11 2001-05-01 Reliv International, Inc. Dietary supplement for nutritionally promoting healthy joint function
JP2002528412A (ja) 1998-10-27 2002-09-03 イェール ユニバーシティ 分泌通路を通る不適当に折り畳まれたタンパク質のコンダクタンス
JP3496200B2 (ja) * 1999-02-12 2004-02-09 株式会社応微研 ウコンの苦味成分を減少させる方法及び苦味成分が減少されたウコン製品
BR0006024A (pt) 1999-04-08 2001-11-06 Metagenics Inc Composição para o tratamento de inflamação e dor em mamìferos
US6673843B2 (en) 1999-06-30 2004-01-06 Emory University Curcumin and curcuminoid inhibition of angiogenesis
US6224877B1 (en) * 1999-09-16 2001-05-01 Council Of Scientific And Industrial Research Process for extraction of curcuminoids from curcuma species
US6576273B2 (en) 2000-08-24 2003-06-10 Chr. Hansen A/S Purification process for improving total yield of curcuminoid colouring agent
US6455078B1 (en) 2000-10-18 2002-09-24 Tzu-Sheng Wu Medicinal herbal composition for treating liver diseases and HIV
EP1357811B1 (en) * 2001-02-09 2008-10-08 New Chapter, Inc. Composition and method for smoke detoxification
KR20020073847A (ko) * 2001-03-16 2002-09-28 주식회사 바이오시너젠 쿠르쿠민 또는 울금 추출물을 포함하는 치매 예방 및치료용 조성물
US6592896B2 (en) 2001-08-06 2003-07-15 The Quigley Corporation Medicinal composition and method of using it
US7037524B2 (en) 2001-10-03 2006-05-02 Herbalscience, Llc Oral delivery of a botanical
DE10157755A1 (de) * 2001-11-27 2003-06-12 Henkel Kgaa Wirkstoffhaltige Gelkapseln und ihre Verwendung
US6991814B2 (en) 2001-12-13 2006-01-31 Council Of Scientific And Industrial Research Herbal medicaments for the treatment of neurocerebrovascular disorders
US20030170326A1 (en) 2001-12-13 2003-09-11 Council Of Scientific And Industrial Research Bioavailability enchancing activity of Zingiber officinale Linn and its extracts/fractions thereof
GEP20084442B (en) * 2001-12-14 2008-08-10 Council Scient Ind Res Compositions for the treatment of neurocerebrovascular disorders
KR20040089733A (ko) 2002-03-12 2004-10-21 카운슬 오브 사이언티픽 앤드 인더스트리얼 리서치 쿠미눔 시미눔 및 이의 추출물 및 분획물의생체이용률/생체내효능 증진 활성
CN1306930C (zh) * 2003-05-05 2007-03-28 广州白云山医药科技发展有限公司 抗病毒软胶囊及其制备方法
JP2004331539A (ja) * 2003-05-06 2004-11-25 Maruzen Pharmaceut Co Ltd 肝臓疾患予防治療剤及び肝臓疾患予防治療用飲食物
CN1302769C (zh) 2003-08-08 2007-03-07 李德山 姜黄油提取物注射水剂及其制备方法和用途
CN1489994A (zh) 2003-08-22 2004-04-21 南京康海医药开发有限公司 姜黄脂溶性苯丙乙烯类成分提取物及其制剂新用途
US20050049299A1 (en) 2003-08-26 2005-03-03 Aggarwal Bharat B. Selective inhibitors of stat-3 activation and uses thereof
CN1319524C (zh) 2003-08-27 2007-06-06 谢恬 姜黄油提取物滴丸及其制备方法和用途
US7205011B2 (en) * 2003-11-14 2007-04-17 Board Of Regents, Acting For And On Behalf Of, University Of Arizona Anti-inflammatory activity of a specific turmeric extract
US7070816B2 (en) * 2003-12-05 2006-07-04 New Chapter, Inc. Methods for treating prostatic intraepithelial neoplasia with herbal compositions
US7067159B2 (en) * 2003-12-05 2006-06-27 New Chapter, Inc. Methods for treating prostate cancer with herbal compositions
US10543277B2 (en) * 2005-05-30 2020-01-28 Arjuna Natural Private Limited Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof
US10286027B2 (en) * 2005-05-30 2019-05-14 Arjuna Natural Extracts, Ltd. Sustained release formulations of curcuminoids and method of preparation thereof
US8859020B2 (en) * 2005-05-30 2014-10-14 Benny Antony Treatment of alzheimer's with a curcuminoid mixture and essential oil of turmeric having 45% Ar-turmerone
US7883728B2 (en) * 2005-05-30 2011-02-08 Arjuna Natural Extracts, Ltd. Composition to enhance the bioavailability of curcumin
US20170202785A1 (en) * 2005-05-30 2017-07-20 Benny Antony Formulation of Curcumin with Enhanced Bioavailability of Curcumin and method of preparation and treatment thereof
PT1890546T (pt) * 2005-05-30 2019-01-23 Antony Benny Método para melhorar a biodisponibilidade da curcumina
US20170042833A1 (en) * 2014-03-12 2017-02-16 Benny Antony Formulation of Curcuminoids with Enhanced Bioavailability of Curcumin, Demethoxycurcumin, Bisdemethoxycurcumin and method of preparation and uses thereof

Also Published As

Publication number Publication date
US10485843B2 (en) 2019-11-26
US7736679B2 (en) 2010-06-15
US20170360869A1 (en) 2017-12-21
PT1890546T (pt) 2019-01-23
US20100217045A1 (en) 2010-08-26
US8153172B2 (en) 2012-04-10
EP1890546B1 (en) 2018-11-28
US8895087B2 (en) 2014-11-25
JP5039032B2 (ja) 2012-10-03
ES2709653T3 (es) 2019-04-17
US20140093594A1 (en) 2014-04-03
US20150037442A1 (en) 2015-02-05
US20070148263A1 (en) 2007-06-28
HUE042590T2 (hu) 2019-07-29
DK1890546T3 (en) 2019-03-11
EP1890546A1 (en) 2008-02-27
EP1890546A4 (en) 2010-01-13
US20110092603A1 (en) 2011-04-21
US8623431B2 (en) 2014-01-07
US20120220666A1 (en) 2012-08-30
US9861677B2 (en) 2018-01-09
WO2006129323A1 (en) 2006-12-07
US7879373B2 (en) 2011-02-01
JP2008545740A (ja) 2008-12-18

Similar Documents

Publication Publication Date Title
HUE042590T2 (hu) Eljárás kurkumin biológiai hasznosíthatóságának javítására
ZA200705425B (en) Method for the manufacture of hydrocarbons
IL188330A0 (en) Processes for the preparation of
IL181303A0 (en) Method for the production of dihydropteridinones
ZA200804264B (en) Process for the preparation of ferri-succinylcasein
ZA200600495B (en) Method of treatment for improved bioavailability
IL213474A0 (en) Processes for the preparation of cyclopropyl-amide derivatives
ZA200704189B (en) Method for the manufacture of extended steel products
EG24870A (en) Method for deodorisation
ZA200601910B (en) Process for the preparation of organosilances
IL190139A0 (en) Method for the determination of poloxamers
EP1964538A4 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL SUBSTANCES
PL1962960T3 (pl) Sposób mikronizowania
PL1937662T3 (pl) Sposób wytwarzania duloksetyny
GB0506349D0 (en) Forming method
PL377704A1 (pl) Sposób wytwarzania naturalnego preparatu
PL373928A1 (pl) Sposób wytwarzania imatinibu
PL378004A1 (pl) Sposób wytwarzania R-pantolaktonu
PL378375A1 (pl) Sposób wytwarzania nanoceramik BaTiO₃
PL377182A1 (pl) Sposób wytwarzania sera niedojrzewającego
PL377916A1 (pl) Sposób wytwarzania optycznie czystego R-(–)-1-okten-3-olu
PL373688A1 (pl) Sposób wytwarzania 7-hydroksyflawonu
PL373925A1 (pl) Sposób wytwarzania kwasów ureidoalkilofosfonowych
PL375688A1 (pl) Sposób wytwarzania emulsji
PL372059A1 (pl) Sposób wytwarzania emulsji